Microcystic adnexal carcinoma (MAC) is a recently described malignant neoplasm of the adnexal structures of skin that shows a marked propensity for early infiltrative and locally aggressive growth. Its banal clinical appearance may lead to a delay in diagnosing the tumor by biopsy, and its multifaceted histologic features may lead to an incorrect tissue diagnosis. Confusion with benign tumors and less aggressive malignancies can lead to inadequate initial treatment and extensive recurrences. We describe three cases of microcystic adnexal carcinoma and review the clinical and histologic features, treatment, and prognosis of this neoplasm.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00006534-198912000-00018DOI Listing

Publication Analysis

Top Keywords

microcystic adnexal
12
adnexal carcinoma
12
histologic features
8
carcinoma
4
carcinoma sclerosing
4
sclerosing sweat
4
sweat duct
4
duct carcinoma
4
carcinoma microcystic
4
carcinoma mac
4

Similar Publications

Periorbital Microcystic Adnexal Carcinoma With Distant Metastases.

Ophthalmic Plast Reconstr Surg

December 2024

Department of Ophthalmology, Liverpool Hospital, Liverpool, New South Wales.

Purpose: Microcystic adnexal carcinoma (MAC) is a locally aggressive adnexal carcinoma of the head and neck, which has a high tendency for recurrence. MAC rarely has distant metastasis, with only one previously reported case originating from the periorbital region. We present a patient with periorbital MAC with distant metastasis and a review of all reported patients with metastatic disease.

View Article and Find Full Text PDF
Article Synopsis
  • Squamoid eccrine ductal carcinoma is a rare tumor with characteristics that fall between squamous cell carcinoma (SCC) and certain sweat gland carcinomas, leading to debates on its classification.
  • The study examined 15 cases of this carcinoma, revealing that most cases had UV signature mutations and TP53 mutations as the most common genetic alterations.
  • Transcriptome analysis indicated that this carcinoma expresses 364 genes more and 525 genes less compared to SCC and sweat gland tumors, reinforcing the idea that it has an intermediate phenotype between these cancer types.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!